Immunohistochemical staining of cleaved Caspase 3 in tumor sections revealed that cancer cell apoptosis was increased by Sorafenib treatment but was even higher upon combination of Sorafenib with depletion of USP29 (Fig. 6d, e). The gene discussed is CASP3; the disease is neoplasm.